Element Capital Management LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Element Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$17.43 - $28.82 $232,498 - $384,429	-13,339 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$12.05 - $20.18 $160,734 - $269,181	13,339 New	13,339 $245,000
Q2 2018 Aug 14, 2018	SELL	$6.37 - $14.02 $751,984 - $1.66 Million	-118,051 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$3.72 - $7.64 $439,149 - $901,909	118,051 New	118,051 $851,000
Q4 2017 Feb 14, 2018	SELL	$3.14 - $4.5 $447,917 - $641,920	-142,649 Closed	0 $0
Q3 2017 Nov 13, 2017	SELL	$1.69 - $4.33 $255,587 - $654,847	-151,235 Reduced 51.46%	142,649 $618,000
Q2 2017 Aug 14, 2017	BUY	N/A	293,884	293,884 $476,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.76B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Element Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Element Capital Management LLC with notifications on news.